PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,953 | +57.0% | 50,671 | +17.2% | 0.00% | – |
| Q1 2023 | $45,828 | -30.3% | 43,234 | 0.0% | 0.00% | – |
| Q4 2022 | $65,716 | +41.1% | 43,234 | +96.8% | 0.00% | – |
| Q3 2022 | $46,566 | -51.0% | 21,965 | -51.3% | 0.00% | – |
| Q1 2022 | $95,129 | -52.7% | 45,085 | -16.7% | 0.00% | – |
| Q4 2021 | $201,000 | -24.2% | 54,138 | +2.1% | 0.00% | – |
| Q3 2021 | $265,000 | -27.4% | 53,037 | -5.3% | 0.00% | – |
| Q2 2021 | $365,000 | +24.1% | 56,007 | +31.2% | 0.00% | – |
| Q1 2021 | $294,000 | -30.8% | 42,673 | +2.5% | 0.00% | – |
| Q4 2020 | $425,000 | +183.3% | 41,641 | -2.7% | 0.00% | – |
| Q3 2020 | $150,000 | -28.2% | 42,787 | 0.0% | 0.00% | – |
| Q2 2020 | $209,000 | +19.4% | 42,787 | -16.8% | 0.00% | – |
| Q1 2020 | $175,000 | – | 51,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |